Breast cancer study halted after just 2 patients enrolled
NCT ID NCT02688803
First seen Dec 10, 2025 · Last updated May 15, 2026 · Updated 17 times
Summary
This study aimed to test a simpler consent process to compare three standard chemotherapy plans for triple-negative breast cancer (TNBC). Only 2 people took part before the study was stopped early. The goal was to see if this new approach could help doctors learn which treatment works best, but the study did not gather enough data to draw conclusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Ottawa Hospital Cancer Centre
Ottawa, Ontario, K2H 8L6, Canada
Conditions
Explore the condition pages connected to this study.